Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lamprecht

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|May 1, 2026
ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort studySebastian Klapa, Katja Bieber, Artem Vorobyev, et al.
Zeitschrift Fur Rheumatologie|December 6, 2017
[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis]Jan Henrik Schirmer, Peer M Aries, Kirsten de Groot, et al.
Experimental Dermatology|May 13, 2014
Co-occurrence of autoantibodies in healthy blood donorsJasper Prüßmann, Wiebke Prüßmann, Andreas Recke, et al.
Clinical Immunology (Orlando, Fla.)|March 4, 2008
Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosisDorin Capraru, Antje Müller, Elena Csernok, et al.
Autoimmunity Reviews|September 20, 2016
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementClodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, et al.
Autoimmunity Reviews|March 14, 2017
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statementAnna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, et al.
Annals of the Rheumatic Diseases|February 24, 2018
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's diseaseCem Gabay, Bruno Fautrel, Jürgen Rech, et al.
The Lancet. Rheumatology|August 25, 2024
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohortKarl Gisslander, Arthur White, Louis Aslett, et al.
The Lancet. Rheumatology|January 22, 2024
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trialNils Venhoff, Wolfgang A Schmidt, Raoul Bergner, et al.
The Journal of Clinical Investigation|October 6, 2015
Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitisArnaud Millet, Katherine R Martin, Francis Bonnefoy, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|May 1, 2026
ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort studySebastian Klapa, Katja Bieber, Artem Vorobyev, et al.
Zeitschrift Fur Rheumatologie|December 6, 2017
[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis]Jan Henrik Schirmer, Peer M Aries, Kirsten de Groot, et al.
Experimental Dermatology|May 13, 2014
Co-occurrence of autoantibodies in healthy blood donorsJasper Prüßmann, Wiebke Prüßmann, Andreas Recke, et al.
Clinical Immunology (Orlando, Fla.)|March 4, 2008
Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosisDorin Capraru, Antje Müller, Elena Csernok, et al.
Autoimmunity Reviews|September 20, 2016
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementClodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, et al.
Autoimmunity Reviews|March 14, 2017
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statementAnna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, et al.
Annals of the Rheumatic Diseases|February 24, 2018
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's diseaseCem Gabay, Bruno Fautrel, Jürgen Rech, et al.
The Lancet. Rheumatology|August 25, 2024
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohortKarl Gisslander, Arthur White, Louis Aslett, et al.
The Lancet. Rheumatology|January 22, 2024
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trialNils Venhoff, Wolfgang A Schmidt, Raoul Bergner, et al.
The Journal of Clinical Investigation|October 6, 2015
Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitisArnaud Millet, Katherine R Martin, Francis Bonnefoy, et al.
Pageof 14